Teleflex Incorporated

Teleflex Inc. is a U.S.-based medical technology company that designs, manufactures, and supplies single-use devices used in critical care, surgical, and diagnostic procedures. Its portfolio serves hospitals and healthcare providers worldwide through direct sales and distributors, with manufacturing and operations spread across North America, Europe, and Asia.

14,9 %

56,2 %

−45,4 %

+17,2 %

2.54

2.01

— Teleflex Incorporated
%
Critical care devices30% Single-use products used in intensive care and emergent hospital procedures.
Surgical and diagnostic devices25% Devices used in common surgical and diagnostic procedures across hospitals.
Vascular access and catheters20% Catheters, access devices, and related products for interventional care.
Anesthesia and respiratory care15% Products supporting airway management, anesthesia, and breathing support.
OEM and specialty products10% Specialty-engineered and original equipment manufacturer products and components.

Teleflex sells primarily to hospitals, healthcare systems, and other healthcare providers that use its devices in...

  • Hospitals and health systemsprimary

    Buy single-use devices for critical care, surgery, and diagnostic procedures.

  • Healthcare providers and clinicsprimary

    Purchase procedure-specific devices used across inpatient and outpatient care.

  • Distributorssecondary

    Resell Teleflex products in markets where indirect channel coverage is needed.

  • OEM and specialty customerssecondary

    Buy selected product lines or components for integration into broader offerings.

Teleflex sells worldwide and reports operating segments for the Americas, EMEA, and Asia Pacific...

  • Sales are global across the Americas, EMEA, and Asia Pacific
  • Manufacturing is concentrated in the Czech Republic, Malaysia, Mexico, and the U.S.
  • Asia includes exposure to China procurement and pricing programs
  • EMEA and Americas support broad hospital and distributor coverage
  • Global footprint helps serve local customers and manage supply chain reach

Teleflex’s strategy centers on expanding its product portfolio, developing new products and line extensions, and...

01
New product developmentmedium-term

Fresh products and line extensions support share gains in procedure-based markets.

02
Geographic expansionmedium-term

Entering new markets reduces dependence on any one region or procedure mix.

03
Operational efficiencyshort-term

Lower-cost manufacturing and distribution improve competitiveness in commoditized categories.

04
Portfolio optimizationmedium-term

Divesting non-core businesses can sharpen focus on higher-priority medical device lines.

Teleflex faces intense competition, product liability exposure, and regulatory risk because its devices are used in...

critical

Product liability and recall exposure

Devices used on seriously ill patients can trigger claims if defects or labeling issues arise.

Scope
Critical care, surgical, and implanted or invasive products
Materiality
high
high

Intense medical device competition

Large and niche competitors can outspend Teleflex on development, marketing, and distribution.

Scope
Product categories sold into hospitals and specialty procedures
Materiality
high
high

Reimbursement and coverage pressure

Customer purchasing decisions depend on third-party coverage and reimbursement levels.

Scope
Hospital and provider purchasing channels
Materiality
high
medium

Cybersecurity and IT disruption

Operational systems support ordering, invoicing, shipping, and customer relationships.

Scope
Enterprise systems and third-party technology providers
Materiality
medium
medium

Foreign exchange and procurement policy risk

International sales and China procurement programs can affect pricing and margins.

Scope
Asia and other non-U.S. markets
Materiality
medium
Inventory valuation and obsolescence
Can affect cost of goods sold and gross profit through reserve adjustments
Restructuring charges
Affects operating expenses and period-to-period comparability
Foreign exchange derivatives
Can create mark-to-market gains or losses in earnings or OCI
Acquisition accounting
Affects revenue mix, amortization expense, and goodwill/intangible balances
Product liability and warranty reserves
Can materially affect operating expense and contingent liabilities

: 29.4.2026